SpyGlass Pharma SGP
NASDAQ SGP
$24.92 -1.58 (-5.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

SpyGlass Pharma (SGP) Income towards Parent Company (2025 - 2026)

Updated

SpyGlass Pharma (SGP) recorded Income towards Parent Company of -$19.86 million in Q2 2026, compared with -$8.68 million a year earlier.

Analysis

SpyGlass Pharma (SGP) Income towards Parent Company (2025 - 2026) Analysis & Trends

For FY2025, SpyGlass Pharma reported Income towards Parent Company of -$39.87 million.

  • Across earlier years, Income towards Parent Company came in at -$29.16 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 SpyGlass Pharma 833.48 Mn 833.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.86 Mn
Jun 30, 2025 -8.68 Mn
API Access

SpyGlass Pharma Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=SGP&period=max&api_key=YOUR_API_KEY